Walden Group Healthcare M&A Blog

  • Walden Group Arranges the sale of Attentus Medical Sales to Medical Specialty Distributors

    10/3/2017
    The Walden Group is pleased to announce that it represented Attentus Medical Sales, Inc.,a provider of specialized products to compounding, specialty, and infusion pharmacies, to Medical Specialty Distributors, LLC, a leading alternate site patient supply chain solutions provider and a portfolio company of New Mountain Capital. To serve the...
    Read More
  • Walden Group Arranges the Sale of Millennium Surgical to Avalign Technologies

    The Walden Group is pleased to announce that it represented Millennium Surgical Corp. in its sale to Avalign Technologies, Inc. Pioneering a new approach, Millennium is an innovative supplier of surgical instruments to OEMs, distributors, hospitals and surgery centers. Utilizing sophisticated web-based marketing tools, electronic cataloging and...
    Read More
  • Walden Group Arranges the sale of Argentum Medical, LLC to Shore Capital Partners

    1/25/2017
    The Walden Group is pleased to announce that it represented Argentum Medical, LLC, an advanced woundcare company, in its sale of equity to Shore Capital Partners. Argentum's core platform technology, Silverlon, is a uniquely designed silver-plated nylon matrix that releases potent silver ions into the wound without staining the skin or increasing...
    Read More
  • EQT (Private Equity) Sells BSN Medical to Svenska Cellulosa Aktiebolaget (SCA)

    12/27/2016
    Sweden's Svenska Cellulosa Aktiebolaget (SCA), $12.3b global hygiene and forest products company, is buying BSN Medical GmbH, a Germany-based manufacturer of woundcare, noninvasive orthopedic  and compression therapy products. The deal weights SCA's business more toward healthcare.  BSN has a major share in several attractive medical product...
    Read More
  • J&J to buy Abbott Medical Optics for $4.3b.

    10/25/2016
    Johnson & Johnson (NYSE: JNJ), a $74.3b manufacturer of pharmaceuticals, medical devices and consumer healthcare products, has agreed to buy Abbott Medical Optics Inc, a global ophthalmic surgical and eye care products company and a unit of Abbott Labs. The deal greatly expands J&J's $7b eye care segment, by adding ophthalmic products...
    Read More